Acadia Pharmaceuticals | ACAD - 应收帐款人

股票价格

21.85

每天变化

-0.60 -2.67%

每月一次

-1.58%

每年

46.55%

Q2 预测

21.49

金融业

USD

USD 1.56B

现金及等价物

USD 819.69M

USD 26.23M

USD 1.06B

USD 277.11M

USD 54.81M

USD 17.39M

USD 35.76M

653

EPS每股收益

USD 1.6

股本和储备

USD 917.27M

USD 257.76M

债务利息支出

USD 0

USD 8.25M

USD 0

USD 3.67B

USD 273.57M

USD 266.6M

USD 17.39M

普通股股本

USD 169.18M

11.61

USD 26.32M

USD 284M

销售和管理费用

USD 146.73M

USD 34.67M

贸易债权人

USD 10.9M

应收帐款人

USD 148.23M

	应收帐款人	更改		日
Acadia Pharmaceuticals	USD 148.23M		8.79M	2025-12
ALKERMES	USD 334.02M		21.08M	2025-12
Alnylam Pharmaceuticals	USD 883.96M		106.39M	2026-03
Biogen	USD 1.79B		76.6M	2026-03
BioMarin Pharmaceutical	USD 908.21M		117.95M	2025-12
Bristol-Myers Squibb	USD 14.36B		164M	2026-03
Cara Therapeutics	USD 2.24M		2.26M	2025-03
Corcept Therapeutics	USD 39.07M		20.71M	2026-03
Cytokinetics	USD 1.81M		6.6M	2025-09
Eisai	JPY 249.06B		25B	2025-12
Eli Lilly	USD 21.18B		1.02B	2026-03
Incyte	USD 1.05B		27.09M	2026-03
J&J	USD 21.33B		3.72B	2025-12
Moderna	USD 71M		113M	2026-03
Neurocrine Biosciences	USD 686.8M		41.2M	2025-12
Pfizer	USD 18.12B		2.02B	2025-09
Prothena	USD 5.16M		0	2023-12
PTC Therapeutics	USD 181.62M		21.45M	2025-12
Sarepta Therapeutics	USD 398.23M		2.49M	2025-12
Ultragenyx Pharmaceutical	USD 112.54M		11.92M	2025-09
Vanda Pharmaceuticals	USD 47.1M		4.35M	2024-12
Vertex Pharmaceuticals	USD 2.05B		106.4M	2025-12